These p53 mutant PDAC cells exhibit enhanced activity of the nuclear factor-κB (NF-κB) signaling pathway compared to p53 null cancer cells and secrete higher levels of the NF-κB target gene tumor necrosis factor-α (TNF-α). The gene discussed is TP53; the disease is cancer.